Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sizable Layoffs Hit Four Life Science Companies

Mid-year doldrums are hitting as multiple pharmaceutical and biotech companies have initiated layoffs across the United States.

Read More »

Havas Health & You Network Names Megan Rokosh as First-Ever Global CMO

Global health-and-wellness marketing network Havas Health & You announced that Megan Rokosh was appointed global CMO.

Read More »

String of promotions, appointments at CMI/Compas

In celebrating the company’s 30th year, CMI/Compas expanded the leadership to accommodate explosive growth.

Read More »

Chris Palmer named Chief Executive Officer of CDM

Chris Palmer was named Chief Executive Officer of the global healthcare advertising network CDM.

Read More »

Bristol-Myers Squibb to Shuffle Execs Once Celgene Acquisition Closes

Bristol-Myers Squibb announced an update to the leadership team for the combined company with Celgene for when the acquisition is completed.

Read More »

QBFox Healthcomm On The Move

Just one year after opening their doors as a full-service healthcare agency, QBFox Healthcomm is moving up … literally.

Read More »

Syneos Health Appoints Patrick Nealon, Head of Oncology

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the appointment of Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development.

Read More »

CMI/Compas Adds EVP, Group Client Director Role, Aligning to Better Serve Clients

CMI/Compas, media buying and planning for the nation’s top healthcare companies and part of WPP (NYSE:WPP), announced the creation of the EVP, Group Client Director role, which will be responsible for client satisfaction and client business leadership overall.

Read More »

W2O Announces Investment from New Mountain Capital; Partnership Focused on Making the World a Healthier Place through Marketing Communications

W2O announced a partnership with New Mountain Capital to accelerate continued growth and scale of the company to meet the evolving needs of its clients to most effectively and efficiently communicate with and influence their key stakeholders in an increasingly digital and mobile world.

Read More »

Dynavax to Lay Off 37 Percent of Staff, CEO to Retire

Dynavax CEO Eddie Gray will step down from his role on Aug. 1, 2019, as the Bay Area company undergoes restructuring to move away from immuno-oncology and prioritize the vaccine business.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom